These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

725 related items for PubMed ID: 15847795

  • 1. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D, Wiessenberg HD, Hart M, Bruins P, Voskuyl A, Daha MR, Hack CE.
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [Abstract] [Full Text] [Related]

  • 2. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
    Wouters D, Brouwer MC, Daha MR, Hack CE.
    Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
    Wouters D, Voskuyl AE, Molenaar ET, Dijkmans BA, Hack CE.
    Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
    [Abstract] [Full Text] [Related]

  • 4. Blood platelets activate the classical pathway of human complement.
    Peerschke EI, Yin W, Grigg SE, Ghebrehiwet B.
    J Thromb Haemost; 2006 Sep; 4(9):2035-42. PubMed ID: 16961611
    [Abstract] [Full Text] [Related]

  • 5. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
    Petersen NE, Elmgreen J, Teisner B, Svehag SE.
    Acta Med Scand; 1988 Sep; 223(6):557-60. PubMed ID: 3389208
    [Abstract] [Full Text] [Related]

  • 6. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
    Biró E, Nieuwland R, Tak PP, Pronk LM, Schaap MC, Sturk A, Hack CE.
    Ann Rheum Dis; 2007 Aug; 66(8):1085-92. PubMed ID: 17261534
    [Abstract] [Full Text] [Related]

  • 7. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.
    Hair PS, Gronemus JQ, Crawford KB, Salvi VP, Cunnion KM, Thielens NM, Arlaud GJ, Rawal N, Krishna NK.
    Mol Immunol; 2010 Jan; 47(4):792-8. PubMed ID: 19896716
    [Abstract] [Full Text] [Related]

  • 8. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA, Senaldi G, Jawad AS, Berry H, Vergani D.
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [Abstract] [Full Text] [Related]

  • 9. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
    Corvetta A, Spaeth PJ, Ghirelli PA, Orecchioni F, Buetler R, Montroni M, Nydegger UE.
    Diagn Immunol; 1983 Apr; 1(4):315-23. PubMed ID: 6333960
    [Abstract] [Full Text] [Related]

  • 10. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
    Gilliam BE, Reed MR, Chauhan AK, Dehlendorf AB, Moore TL.
    Clin Exp Rheumatol; 2011 Apr; 29(6):1049-56. PubMed ID: 22153664
    [Abstract] [Full Text] [Related]

  • 11. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro.
    Bruins P, te Velthuis H, Eerenberg-Belmer AJ, Yazdanbakhsh AP, de Beaumont EM, Eijsman L, Trouwborst A, Hack CE.
    Thromb Haemost; 2000 Aug; 84(2):237-43. PubMed ID: 10959695
    [Abstract] [Full Text] [Related]

  • 12. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE, Moss IK, Mumford P, Horsfall A, Maini RN.
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [Abstract] [Full Text] [Related]

  • 13. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes.
    Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJ, Hack CE.
    J Immunol; 1996 Jul 01; 157(1):473-9. PubMed ID: 8683153
    [Abstract] [Full Text] [Related]

  • 14. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
    Tomooka K.
    Fukuoka Igaku Zasshi; 1989 Oct 01; 80(10):456-66. PubMed ID: 2613159
    [Abstract] [Full Text] [Related]

  • 15. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK, Hamilton AO, Yeung-Laiwah AC, Whaley K.
    Clin Exp Immunol; 1984 Nov 01; 58(2):486-92. PubMed ID: 6333948
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F, Kijlstra A.
    Immunology; 1985 Mar 01; 54(3):449-56. PubMed ID: 3844370
    [Abstract] [Full Text] [Related]

  • 17. Classical pathway of complement activation in mammalian kidneys.
    Zwirner J, Felber E, Burger R, Bitter-Suermann D, Riethmüller G, Feucht HE.
    Immunology; 1993 Oct 01; 80(2):162-7. PubMed ID: 8262545
    [Abstract] [Full Text] [Related]

  • 18. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
    Duvall MR, Hwang HY, Boackle RJ.
    Immunobiology; 2010 May 01; 215(5):395-405. PubMed ID: 19586684
    [Abstract] [Full Text] [Related]

  • 19. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.
    Zwirner J, Dobos G, Götze O.
    J Immunol Methods; 1995 Oct 12; 186(1):55-63. PubMed ID: 7561148
    [Abstract] [Full Text] [Related]

  • 20. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB, Sjöholm AG.
    Behring Inst Mitt; 1993 Dec 12; (93):292-8. PubMed ID: 8172579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.